| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-09 | Dr. Keith N. G. BradleyIndependent Director | -882.00 | 12.28k | Sale to Issuer | 13.92 | 88.25k | -0.99% |
| 2026-03-11 | Mr. Harvinder Pal SinghExec. VP & President of International Business | 18.92k | 0.00 | Derivative Exercise and Retained Stock | - | 35.42k | 114.68% |
| 2026-03-10 | Mr. Harvinder Pal SinghExec. VP & President of International Business | -1.22k | 11.65k | Derivative Exercise and Sale | 9.55 - 9.61 | 35.42k | - |
| 2026-03-11 | Mr. Harvinder Pal SinghExec. VP & President of International Business | -5.44k | 52.24k | Sale to Issuer | 9.61 | 35.42k | -13.30% |
| 2026-03-10 | Mr. Robert T. DavisExec. VP & President of Tissue Technologies | -9.17k | 88.12k | Sale to Issuer | 9.55 - 9.61 | 66.39k | -12.14% |
| 2026-03-10 | Mr. Michael J. McBreenChief Commercial Officer | -9.60k | 92.12k | Sale to Issuer | 9.55 - 9.61 | 60.74k | -13.65% |
| 2026-03-10 | Mr. Jeffrey A. MosebrookSenior VP of Finance & Principal Accounting Officer | -1.15k | 11.00k | Sale to Issuer | 9.55 - 9.61 | 35.45k | -3.13% |
| 2026-03-11 | Ms. Lea Daniels KnightExec. VP & CFO | -8.09k | 77.74k | Sale to Issuer | 9.61 | 50.49k | -13.81% |
| 2026-03-11 | Ms. Chantal Veillon-BertelootExec. VP & Chief HR Officer | -5.42k | 52.09k | Sale to Issuer | 9.61 | 22.23k | -19.60% |
| 2026-01-06 | Ms. Mojdeh Poulインサイダー | -1.39k | 18.25k | Derivative Exercise and Sale | 13.13 | 0.00 | - |
| 2025-11-05 | Dr. Jeffrey Alan GravesIndependent Director | 9.00k | 102.15k | 買い | 11.35 | 41.09k | 28.05% |
| 2025-10-12 | Mr. Harvinder Pal SinghExec. VP & President of International Business | 8.68k | 0.00 | Derivative Exercise and Retained Stock | - | 21.94k | 65.53% |
| 2025-10-12 | Mr. Harvinder Pal SinghExec. VP & President of International Business | -3.28k | 43.77k | Derivative Exercise and Sale | 13.34 | 21.94k | - |
| 2025-09-01 | Ms. Chantal Veillon-BertelootExec. VP & Chief HR Officer | -3.55k | 53.73k | Sale to Issuer | 15.13 | 27.65k | -11.38% |
| 2025-08-14 | Dr. Stuart M. EssigCEO, President & Chairman | -200.00k | 2.72M | Other Disposition | 13.62 | 1.79M | -10.07% |
| 2025-07-03 | Ms. Lea Daniels KnightExec. VP & CFO | -2.56k | 34.55k | Sale to Issuer | 13.49 | 58.58k | -4.19% |
| 2025-07-03 | Mr. Jeffrey A. MosebrookSenior VP of Finance & Principal Accounting Officer | -3.35k | 45.12k | Sale to Issuer | 13.49 | 36.60k | -8.37% |
| 2025-07-01 | Mr. Jeffrey A. MosebrookSenior VP of Finance & Principal Accounting Officer | -937.00 | 12.42k | Sale to Issuer | 13.25 | 39.95k | -2.29% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。